WO2024028788A1 - A consumable gel for health ingredients - Google Patents
A consumable gel for health ingredients Download PDFInfo
- Publication number
- WO2024028788A1 WO2024028788A1 PCT/IB2023/057834 IB2023057834W WO2024028788A1 WO 2024028788 A1 WO2024028788 A1 WO 2024028788A1 IB 2023057834 W IB2023057834 W IB 2023057834W WO 2024028788 A1 WO2024028788 A1 WO 2024028788A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- water
- oil
- gel
- gelling agent
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title claims abstract description 75
- 230000036541 health Effects 0.000 title claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 76
- 235000019640 taste Nutrition 0.000 claims abstract description 46
- 239000002552 dosage form Substances 0.000 claims abstract description 44
- 239000000839 emulsion Substances 0.000 claims abstract description 44
- 150000002632 lipids Chemical class 0.000 claims abstract description 36
- 230000000873 masking effect Effects 0.000 claims abstract description 24
- 239000000499 gel Substances 0.000 claims description 80
- 239000003921 oil Substances 0.000 claims description 50
- 235000019198 oils Nutrition 0.000 claims description 49
- 239000003349 gelling agent Substances 0.000 claims description 38
- 229920001817 Agar Polymers 0.000 claims description 29
- 235000010419 agar Nutrition 0.000 claims description 27
- 229920000642 polymer Polymers 0.000 claims description 26
- 239000008272 agar Substances 0.000 claims description 25
- 235000010443 alginic acid Nutrition 0.000 claims description 23
- 229920000615 alginic acid Polymers 0.000 claims description 23
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 21
- 229940072056 alginate Drugs 0.000 claims description 21
- 239000003995 emulsifying agent Substances 0.000 claims description 15
- 229920000936 Agarose Polymers 0.000 claims description 14
- 150000002500 ions Chemical class 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 239000004033 plastic Substances 0.000 claims description 8
- 229920003023 plastic Polymers 0.000 claims description 8
- 235000019486 Sunflower oil Nutrition 0.000 claims description 7
- 239000004006 olive oil Substances 0.000 claims description 7
- 235000008390 olive oil Nutrition 0.000 claims description 7
- 239000002600 sunflower oil Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 235000010755 mineral Nutrition 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 230000036571 hydration Effects 0.000 claims description 5
- 238000006703 hydration reaction Methods 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000010902 straw Substances 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000006186 oral dosage form Substances 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 230000035622 drinking Effects 0.000 claims description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229940068968 polysorbate 80 Drugs 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 239000011248 coating agent Substances 0.000 abstract description 4
- 238000000576 coating method Methods 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 18
- 238000009472 formulation Methods 0.000 description 10
- 235000015110 jellies Nutrition 0.000 description 9
- 235000010413 sodium alginate Nutrition 0.000 description 9
- -1 such as Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 8
- 239000008274 jelly Substances 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000000661 sodium alginate Substances 0.000 description 7
- 229940005550 sodium alginate Drugs 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 244000179970 Monarda didyma Species 0.000 description 6
- 235000010672 Monarda didyma Nutrition 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 230000009747 swallowing Effects 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000010410 calcium alginate Nutrition 0.000 description 4
- 239000000648 calcium alginate Substances 0.000 description 4
- 229960002681 calcium alginate Drugs 0.000 description 4
- 229910001424 calcium ion Inorganic materials 0.000 description 4
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000010241 potassium sorbate Nutrition 0.000 description 4
- 239000004302 potassium sorbate Substances 0.000 description 4
- 229940069338 potassium sorbate Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000001354 calcium citrate Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000013337 tricalcium citrate Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 235000013367 dietary fats Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 235000010408 potassium alginate Nutrition 0.000 description 2
- 235000007715 potassium iodide Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DCQFFOLNJVGHLW-ZNVMLXAYSA-N (1s,4s,5r,8r)-2,6-dioxabicyclo[3.2.1]octane-3,4,8-triol Chemical compound O[C@H]1[C@@]2([H])OC[C@]1([H])OC(O)[C@H]2O DCQFFOLNJVGHLW-ZNVMLXAYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- IMWCPTKSESEZCL-SPSNFJOYSA-H (e)-but-2-enedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O IMWCPTKSESEZCL-SPSNFJOYSA-H 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- JPLATTLXZFUKRQ-UHFFFAOYSA-N Agarobiose Natural products OCC1OC(OC2C(O)COC2C(O)C=O)C(O)C(O)C1O JPLATTLXZFUKRQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical group OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- ZWTDDXLSKVNYRL-UHFFFAOYSA-N NC(=N)N(C)CC(O)=O.NC(=N)N(C)CC(O)=O.NC(=N)N(C)CC(O)=O.OC(=O)C(O)CC(O)=O Chemical compound NC(=N)N(C)CC(O)=O.NC(=N)N(C)CC(O)=O.NC(=N)N(C)CC(O)=O.OC(=O)C(O)CC(O)=O ZWTDDXLSKVNYRL-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- SWAHNYZETRJYMT-UHFFFAOYSA-L calcium;2-hydroxy-2-methylbutanoate Chemical compound [Ca+2].CCC(C)(O)C([O-])=O.CCC(C)(O)C([O-])=O SWAHNYZETRJYMT-UHFFFAOYSA-L 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 229940046374 chromium picolinate Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 229960004826 creatine monohydrate Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 230000002361 ketogenic effect Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229920005684 linear copolymer Polymers 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229960000869 magnesium oxide Drugs 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- XVFFIWOHZBHTES-UHFFFAOYSA-L magnesium;potassium;dihydroxide Chemical compound [OH-].[OH-].[Mg+2].[K+] XVFFIWOHZBHTES-UHFFFAOYSA-L 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- RAKQPZMEYJZGPI-LJWNYQGCSA-N menaquinone-7 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 RAKQPZMEYJZGPI-LJWNYQGCSA-N 0.000 description 1
- 235000009464 menaquinone-7 Nutrition 0.000 description 1
- 239000011700 menaquinone-7 Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Definitions
- a CONSUMABLE GEL FOR HEALTH This invention relates to a dosage form comprising one or more health ingredients, particularly, but not exclusively, dietary, nutritional or pharmaceutical ingredients.
- the dosage form is a stable, shearable, gel capable of delivering, particularly, multiple health ingredients in a single dosage form including at least one ingredient that requires taste masking, such as exemplified by bergamot, a bitter tasting ingredient.
- the dosage form may be used in human or animal health.
- the dosage form is, particularly, but not exclusively, capable of delivering high doses of dietary, nutritional or pharmaceutical ingredients including: water soluble, water insoluble and/ or lipid soluble ingredients, in a single delivery vehicle which would not readily lend themselves to delivery via tablets or capsules.
- “high” is meant at least 1g of one or more health ingredients, although the at least one ingredient that requires taste masking may be present in amounts of from 0.1g, through 0.25g and 0.5g to 1g or more.
- Taste masking is achieved through the use of a high concentration oil/ water emulsion which is stabilised in a shearable gel and which releases its’ load when sheared, the oil articulsion droplets providing a temporary coating on the tongue blunting the taste of the ingredient requiring masking.
- “high concentration” oil/ water emulsion is meant at least or over 14% by weight of the lipid based carrier as compared to the water content of the dosage form.
- BACKGROUND [0006] One of the most important factors in successfully developing health ingredients, particularly dietary, nutritional or pharmaceutical ingredients is ensuring patient compliance.
- multiple product formats are used to deliver each of multiple e.g. nutritional or other health, e.g. active pharmaceutical ingredients (API’s), products. The varied nature and number of such products leads to significant variability in compliance.
- API active pharmaceutical ingredients
- These health products, dietary, nutritional or pharmaceutical products may be preventative or curative in nature. They include: prescription products, over-the-counter (OTC) products, and nutraceuticals and dietary supplements including, for example, products containing: vitamins, minerals, elements, proteins, carbohydrates, lipids, extracts of plant origin e.g.
- the organoleptic properties may relate to aspects of product taste, product consistency, product texture, product mouth feel, longevity of taste and any other organoleptic sensation. Ingredients with unpleasant tastes are particular challenging and the focus of the claimed invention addresses products including such ingredient(s).
- Some products require a separate drink to facilitate swallowing or to wash residues from the mouth, or a separate solid composition to be co-administered.
- Examples include: replacement sugar products for hypoglycaemia, and whey protein, which is poorly dispersed in liquids, and is additionally required in large volumes.
- a delivery device may be required, such as a spoon, a syringe, or some other metering device to aid consumption and dose delivery.
- These highly viscous pastes or gel products are those that will flow but tend to flow slowly, with a high internal resistance and a consistency like honey or ketchup.
- These known highly viscous pastes may be Newtonian or non-Newtonian fluids and may be shear thinning or shear thickening in nature. However, they all share the property that despite a degree of resistance, they plastically deform under stress – even where such behaviour is also known to have a threshold, such as Bingham plastic behaviour.
- these viscous pastes have a viscosity between about 5000 and about 50,000 cP.
- set refers to jelly materials that set, and do not exhibit plastic behaviour upon stress, but rather behave elastically upon stress, to a failure point where the structure of the jelly breaks to irreversibly create new interfaces.
- Applicant addressed this general problem in WO2019/215641 by developing a base gel comprising two different gelling agents: x a primary gelling agent which was an agarose-based polymer gelling agent, such as, an agar, and x a polyvalent ion gelled polymer which was an alginate-based polymer gelling agent, such as, but not limited to calcium alginate.
- x a primary gelling agent which was an agarose-based polymer gelling agent, such as, an agar
- polyvalent ion gelled polymer which was an alginate-based polymer gelling agent, such as, but not limited to calcium alginate.
- the agarose-based polymer provides the key functional characteristics, namely it forms, in the amounts provided, a firm hydrated gel, with a bloom grade of between 100 and 250, which does not exhibit plastic behaviour upon stress, but rather behaves elastically upon stress, to a failure point where the structure of the gel breaks or shears irreversibly releasing water and creating new interfaces, making it more fluid when ingested, such that it is a drinkable gel.
- the specification teaches forming emulsions incorporating up to 10% by weight of an oil or lipophilic components based on the water content of the dosage form.
- This application addresses a specific challenge of taste masking in agarose-based polymer gels (which can be sheared to release water) and incorporate oils.
- an oral dosage form comprising x an ingredient requiring taste masking, x a first gelling agent, which is an agarose-based polymer gelling agent present in concentrations of between 0.001g (1mg) and 0.03g (30mg) per gram of water which concentration ensures hydration of, and the formation of, a firm gel with a bloom of between 100 and 250, and which does not exhibit plastic behaviour upon stress, but rather behaves elastically upon stress, to a failure point where the structure of the gel breaks or shears to irreversibly create new interfaces, making it more fluid when ingested, such that it is a drinkable gel; and x an oil/ water
- the first gelling agent which is an agarose-based polymer gelling agent is present in concentrations of between 0.001g (1mg) and 0.02g (20mg) per gram of water
- the premise of the invention is based around ensuring droplets of emulsified oil are released from the gel when it shears such that they temporarily coat the tongue, blunting the taste of any ingredient(s) incorporated in the gel which are unpleasant (to receptors on the tongue).
- the invention requires sufficient lipid-based carrier (oil) and emulsifier to achieve its’ function as an effective taste masker whilst retaining the stability of the gel.
- stable By stable is meant there is no phase separation of the oil and water components of the emulsion, and that the ingredient(s) did not precipitate out. [0029] Selecting an oil that also provides desirable organoleptic properties was also required. [0030] Any suitable oil including vegetable oils, seed oils, and marine oils can be used together with blends thereof. [0031] Preferred oils were olive oil, sunflower oil, canola oil, coconut oil and oils containing medium chain triglycerides. Olive oil was particularly favoured for its neutral and organoleptic properties.
- the invention can be used with a single agarose based gelling agent, and it is the greater concentration of the emulsified oil that provides the effective taste masking – since it is the release of the emulsified oil on shearing that provides a “protective” (taste blunting) coating to the tongue.
- Agar proved particularly beneficial in providing enhanced stability.
- Applicant has determined that the optimum concentration of emulsified oil (by weight) is between 14% and 28% by weight of oil to water, although Applicant has determined that it is possible, in some circumstances, to get as much as 30% by wt of oil to water.
- the emulsified oil comprises at least 20% by weight the lipid based carrier.
- the incorporation of an emulsifier further improves performance.
- a preferred emulsifier is one of lecithin, polyethylene glycol (PEG) and Polysorbate 80.
- the emulsifier should be present in an amount of from 0.1% to as much as 6.0% by weight. A preferred range is from 3% to 5%. Many other benefits of these shearable gels are as disclosed in WO2019/215641.
- a firm gel is a “set” gel or jelly characterised in an industrial and scientific context by the Bloom test, which is used to provide a relative firmness and strength of these gels. This test originated in 1925 by Oscar T.
- Bloom The test determines the weight in grams needed by a specified plunger (normally with a diameter of 0.5 inch (11mm) to depress the surface of the gel by 4 mm, without irreversibly breaking the gel to create new interfaces, at a specified temperature. This result is the Bloom grade. A higher number indicates a stiffer product. For example, gelatin used in food usually runs from 125 Bloom to 250 Bloom. [0039] For the purpose of this document the terms gel and jelly are interchangeable. [0040] A set gel or jelly is somewhat elastic which means that under stress they deform, but when that stress is released they substantially return back to their original form.
- the oral dosage form of the invention may typically be provided in a volume of between 5ml and 250ml, depending on use, and is delivered from a container.
- agarose-based polymer gelling agent is preferaly, an agar.
- the agarose-based polymer gelling agent also advantageously behaves as an emulsifier so that additional emulsifiers are required in lesser amounts.
- a polyvalent ion gelled polymer when used, is most preferably an alginate-based polymer gelling agent, such as, but not limited to calcium alginate. Alternatives include, guar gum, gellan gum, xanthan gum, pectin and kudzu.
- a particularly favoured combination of gelling agents comprise agar as the primary gelling agent and calcium alginate as the secondary gelling agent.
- Agar consists of a mixture of two polysaccharides: agarose and agaropectin, with agarose making up about 70% of the mixture.
- Agarose is a linear polymer, made up of repeating units of agarobiose, a disaccharide made up of D-galactose and 3,6-anhydro-L- galactopyranose.
- Agaropectin is a heterogeneous mixture of smaller molecules that occur in lesser amounts and is made up of alternating units of D-galactose and L-galactose heavily modified with acidic side-groups, such as sulphate and pyruvate. Any known variant of Agar may be used in the invention. [0049] Agar exhibits hysteresis, melting at 85°C and solidifying at from 32°C to 40°C.
- the gelling also helps provide stability, at room temperature (and above), meaning cold storage can be avoided.
- the most common alginate used in food is sodium alginate.
- sodium alginate In order to form a gel, sodium alginate needs to come into contact with divalent ions, such as calcium (Ca2+).
- a calcium salt such as the chloride or citrate
- a gel forms as the sodium ions (Na+) are exchanged with calcium ions (Ca2+) and the polymers become crosslinked.
- the divalent ions such as calcium
- monovalent ions such as sodium
- the gels are either thermo-reversible (at low concentrations) or thermos-irreversible (at high concentrations).
- Alginic acid is a linear copolymer with homo-polymeric blocks of (1-4)-OLQNHG ⁇ -D- mannuronate (M), and its C-5 epimer, ⁇ -L-guluronate (G), which are covalently linked together in different sequences or blocks.
- Sodium alginate is the sodium salt of alginic acid. Its empirical formula is NaC6H7O6. Sodium alginate is a gum, extracted from the cell walls of brown algae.
- Potassium alginate is a chemical compound that is the potassium salt of alginic acid. Its empirical chemical formula is KC 6 H 7 O 6 .
- Calcium alginate made from sodium alginate from which the sodium ion has been removed and replaced with calcium, has the chemical formula C 12 H 14 CaO 12 .
- the gel formulation of the invention can be used to deliver unpleasant tasting ingredients, including those which are: i) Water soluble; ii) Water insoluble; or iii) Lipids [0057] .
- a dose including upwards of 0.1g of at least one ingredient requiring taste masking and optionally, between 1g and 40g of additional ingredients is delivered in a volume of between 5 and 45 ml of gel.
- These ingredients can include other nutraceutical or health ingredients.
- the base gel formulation can be used to load a single ingredient requiring taste masking, but the format makes it particularly effective for delivering multiple health ingredients, including the ingredient requiring taste masking, in a simple to take, simple to use dosage form which can retain ingredients which would typically be difficult to formulate in a single dosage form due to their different properties and can be administered orally by squeezing or sucking the gel from its container.
- a single ingredient requiring taste masking is most likely to be delivered in a smaller volume format (5ml to 25ml), whereas a larger format (25ml to 250ml) is preferred where multiple health ingredients, particularly those required in large doses, and are required alongside the ingredient(s) requiring taste masking.
- Such multiple health ingredients include, for example, proteins, carbohydrates, dietary fats, vitamins and minerals.
- the Proteins optionally include: milk protein concentrate, whey protein concentrate, soya protein isolate, and sodium caseinate which may additionally include Amino Acids such as one or more of: L-Glutamine, L-Glycine, L-Leucine, L-Isoleucine, L-Valine, Beta Alanine, L-Arginine, and Taurine.
- the Carbohydrates optionally include, for example: maltodextrin, inulin, fructose, and glucose syrup.
- the Dietary Fats optionally include: vegetable fats and oils, fish oils, coconut oil, mono, di and triglycerides of fatty acids, and lecithin.
- the Vitamins optionally include: Vitamin C (Ascorbic Acid), Vitamin K (Menaquinone-7), Vitamin E (dl-Alpha Tocopheryl Acetate), Niacin (Niacinamide), Vitamin A (Retinyl Acetate), Pantothenic Acid (Calcium D-Pantothenate), D-Biotin, Folic Acid, Vitamin D (Cholecalciferol), Vitamin B6 (Pyridoxine Hydrochloride), Riboflavin (Riboflavin 5 Phosphate Sodium), Thiamin (Thiamin Hydrochloride), Vitamin B12 (Cyanocobalamin), Creatine Monohydrate, beta carotene, lutein, lycopene oleoresin, choline chloride, L- carnitine, nic
- the Minerals optionally include Essential and Trace Mineral sources and salts such as one or more of: Tri-potassium Citrate, Sodium Chloride, Trisodium Citrate, Magnesium Oxide, Zinc Gluconate, Iron Fumarate, Manganese Gluconate, Copper Gluconate, Potassium Iodide, Sodium Molybdate, Chromium Picolinate, sodium selenite, chromium chloride, potassium iodide, sodium fluoride, sodium chloride, potassium chloride, calcium hydroxide, sodium ascorbate, magnesium hydroxide potassium hydroxide, ferrous lactate, zinc sulphate, manganese sulphate, and Phosphates such as one or more of sodium triphosphate, tricalcium phosphate, potassium phosphate.
- Essential and Trace Mineral sources and salts such as one or more of: Tri-potassium Citrate, Sodium Chloride, Trisodium Citrate, Magnesium Oxide, Zinc Gluconate, Iron Fumar
- Antioxidants such as one or more of: ascorbyl palmitate, vitamin C (ascorbic acid) and vitamin E (d-alpha tocopherol).
- a pH modifier such as one or more of: citric acid, and ascorbic acid, being used in amounts to provide a pH of from 4 to 7.
- Preservatives such as sorbic acid. or a salt thereof e.g. potassium sorbate
- the gel of the is used to deliver ingredients in the form of an entrapped stable emulsion.
- the lipid component for example, sunflower or olive oil
- the lipid component is emulsified with the water, usually with stirring, and then caused to gel with the agar. Additional emulsifying agents may be added to facilitate the emulsification prior to gelling.
- Typical food grade or pharmaceutical grade emulsifiers such as, for example a lecithin, esters of monoglycerides of fatty acids and mono, di and tri glycerides of fatty acids are added.
- the provision of multi-phase combinations can be accomodated. For example, an ingredient may be more stable in an oil in water emulsion.
- the set gel formed can trap & immobilise multiple phases enhancing stability as well as e.g. masking taste.
- the set gel is easily sheared during delivery to form new wet interfaces thereby facilitating delivery and taste masking through the release of the emulsion.
- the formulation In its stored state the formulation has a firm jelly form, is stable at room temperature, but when sucked or otherwise subjected to a gentle force, shears to create new wet interfaces which facilitate swallowing. Swallowing is eased because the gel interfaces created are slippery because they are inherently wet, due to the water within the structure.
- This novel formulation provides a chemically and physically stable matrix which can be used to entrap water soluble components, non-water soluble lipids, and lipid soluble components alike and provide effective taste masking.
- the gels of the present invention provide minimal residues, other than displaced water, and are very much easier to swallow as a set jelly will shear on sucking in contrast to alternative solid/semi-solid formats that are plastic (not elastic).
- the shear because they shear, they release components quickly, even in high doses, and the released emulsion provides additional taste masking.
- the platform is highly flexible in allowing different health ingredients to be provided in combinations in a single dosage form which has benefits over the alternatives currently on offer.
- an alginate means that some beneficial calcium salts can be incorporated as part of the gelling process.
- Calcium citrate may also enhance flavour.
- Solid suspensions may include nano-milled materials, such as, curcumin or glucosamine in a format which may enhance their bioavailability.
- Agar provides clear gels, without coloured specks. However, Agar and alginate gels are also visually very clear, but more importantly the alginate cross links provide a more structured gel with a different gelling mechanism to the carbohydrate non-ionic gelled polymers improving versatility and performance.
- Agar and Alginate should be used in particular ratios (w/w).
- the preferred ratios favour an excess of agar to alginate, and thus a ratio of between 8:1 to greater than 1:1, more preferably 5:1 to greater than 1:1 and most preferably about 3: greater than 1 Agar to Alginate is preferred.
- the Agar acts as an emulsifier and gelling agent, whilst the alginate together with the metal 2+ ions (Ca2+, Mg2+, Zn2+) form a structured gel counteracting the effect of these ions where only Agar is present.
- Agars and alginates are both suitable for vegans, vegetarians and most religious diets whereas gelatine is not, as it’s an animal protein, usually obtained from pigs.
- the advantage of combining agar and alginate gels is that they are less sensitive to temperature effects than other gelling agents. They are also less affected by components that may inhibit gelation, such as oils, changes in pH, and high concentrations of complex carbohydrates, such as, maltodextrins.
- Agar and alginate gels also tend to be faster setting, which is an advantage in manufacturing, facilitating faster and more robust production.
- the lipids used in the practising of the invention included any suitable food grade oil of animal or plant origin. Non-limiting examples include: corn oil, olive oil, sunflower oil, and coconut oil. The lipid material may advantageously include lipid vitamins such as any of vitamin D or vitamin E.
- Other preferred features include [0088] A dosage form including one or more health ingredients which are water soluble ingredients and lipid soluble ingredients. [0089] A dosage form wherein the one or more water soluble health ingredients are selected from the group comprising or consisting of water soluble vitamins, carbohydrates, sugars and amino acids.
- a dosage form wherein the one or more lipid-soluble ingredients are selected from the group comprising or consisting of: oils, particularly fish and algal oils, DHA, EPA and lipid soluble vitamins D and E.
- a dosage form comprising one or more of a protein, vitamin, mineral, trace elements and a plant or marine extracts.
- a dosage form further comprising a second gelling agent which is a polyvalent ion gelled polymer gelling agent which is an alginate-based polymer gelling agent.
- the first gelling agent is present in an amount greater than the second gelling agent and more preferably still the agarose-based polymer gelling agent and alginate-based polymer gelling agent are present in a ratio of from greater than 1:1 to 3:1.
- the dosage form is packaged in either: a pouch with an opening for facilitating the drinking of the gel by squeezing and/ or sucking; a sachet or straw; a syringe; or any other packaging facilitating delivery by sucking, squeezing or pushing the gel from the packaging.
- Benefits of the invention include: x Taste masking: The gels of the invention allows any mixture of nutrients and most poor, strong & unpleasant flavours – such as bitterness, sweetness, fish oils, curcumin (spice/peppery) to be masked. x Large volumes of nutrients may additionally be formulated in one easy to consume dosage form: Multiple ingredients and large doses can be combined in a single dosage form.
- x Overcomes choking risks posed by tablets Gels are much easier to swallow than pills. The format aids all swallowing issues, whether young children or the elderly or merely those who have a predisposed swallowing problem.
- x Includes water as an ingredient. The presence of “locked up” but “releasable” water also ensure hydration is achieved, even if released as an emulsion, and no additional fluids are required to enable the product to be swallowed. This also helps aid digestion and provides an improved mouth feel.
- Fig 1 is an illustration of a dispensing dosage form of the invention.
- DETAILED DESCRIPTION [00100] The general process for the preparation of a gel formulation is set out in Example 1 below: Example 1 Production methodology [00101] Any water-soluble ingredients are dissolved in water first. These may include a nutritional ingredient such as glucose, as well as preservatives and dilute acids (for pH control). An exemplary preservative is potassium sorbate, and an exemplary pH control agent, if required, is a weak acid, such as, citric acid, ascorbic acid, acetic acid or dilute HCl.
- the solution is preferably stirred and heated to near boiling.
- the agar and optionally sodium alginate are added slowly, to allow for gradual hydration, with steady constant stirring, ensuring satisfactory dispersion or dissolution.
- the dispersion or solution is kept at or around boiling point for a time, between 4-5 minutes, sufficient to ensure proper hydration, especially of the agar.
- a separate emulsion is formed oil , water and any other ingredient to be incorporated into the emulsion.
- the two components are then mixed and the finished product is filled into e.g. sachets and allowed to cool such that it forms a firm gel.
- the sachet may be a simple sachet or tube for small volumes (5-25ml) or for larger volumes (25 to 250ml) a pouch, as illustrated in Fig 1.
- the pouch (1) is formed from, for example, plastics or foil layers that are sealed together around an edge (3) incorporating a filling and dispensing aperture comprising a plug (4), spout (5) and cap (6).
- the pouch is filled through the mouth piece (5) and is secured with a cap (6) which may be provided with a frangible seal.
- the subject removes the cap and drinks the gel by squeezing it and/ or sucking it from the pouch (1) through the spout (5).
- Alternative packaging for delivery may include a sachet or straw; a syringe; or any other packaging facilitating delivery by sucking, squeezing or pushing the gel from the packaging.
- a sachet or straw When preparing the gel it is desirable to limit the heating period to minimise water loss from evaporation as excessive evaporation can lead to product variability.
- the agar is used in concentrations of between 0.001g (1mg) and 0.02g (20mg) per gram of water.
- the alginate is used in concentrations of between 0.0005g (0.05mg) and 0.01g (10mg) per gram of water. More preferably between 0.001g (1mg) and (0.008g (8mg) per gram of water, and most preferably between 0.001g (1mg) and 0.005g (5mg) per gram of water.
- a source of divalent ions is added to enhance the alginate gel formation.
- Suitable ingredients include calcium, zinc and/ or magnesium salts.
- calcium citrate, magnesium citrate or zinc citrate are good forms of soluble salts and can also provide mineral supplementation. Other salts may however be used.
- Favoured lipids for forming the emulsion are neutral oils such as olive oil and sunflower oil. Typically, the lipid level is added in concentrations of from 14 to 28%, but in certain circumstances up to 30%, w/w of the total water. The water component may be “split” and the gel and emulsion mixed.
- a mechanical homogeniser such as a Silverson homogeniser, is advantageously used to facilitate the formation of an emulsion.
- any known food grade emulsifier may be added to improve the emulsion quality and stability, such as, for example, a lecithin.
- the emulsifier is non-animal sourced, such as soya lecithin, rather than egg lecithin.
- the emulsion is, as noted above, made as a separate cool water mix precursor, and is combined with a separate hot agar in water precursor, (the water being split as appropriate) to speed cooling and gel formation.
- Further components may be dissolved or dispersed into the gel or emulsion. Where a nutritional component is neither water or lipid soluble, this may be prepared as a suspension in either lipid or water.
- this component is milled to a fine particle size, as this may improve suspension stability, and may also improve bioavailability.
- the insoluble component may be milled in wet or dry conditions, and may be ball milled, or media milled or nano-milled or milled in a high shear homogeniser. The milling may be conducted in the presence of a milling aid, such as leucine, sodium lauryl sulphate, and metal stearates. [00115] After heating, this liquid formulation can be metered hot into the desired containers and allowed to set as a gel. [00116] More specifically for e.g.
- the gel production process involves the following: [00118] Weigh the non-gelling agents (e.g. glucose, potassium sorbate, water) in appropriate scaled quantities and add them to a suitable mixing vessel, in the order of e.g. Glucose (or other carbohydrate) as required; potassium sorbate or other preservative as needed, and water. [00119] Apply steady stirring, e.g. at lab scale this is a magnetic stirrer bar. Cover to minimise evaporation and water loss. [00120] Pre-weigh the specified nutrients required for composition. Mix these non-gelling ingredients while applying heat to the vessel contents.
- the non-gelling agents e.g. glucose, potassium sorbate, water
- the Bloom test is used to characterise the resulting grade of the set gel.
- a Bloom grade of at least 100 through 110, 120, 130 and 140 is obtained.
- a Bloom grade of less than 250, less than 220, less than 200 to less than 180 is obtained.
- An optimal Bloom grade of between 140 and 180 is desired.
- a preferred base gel, into which a plurality of ingredients promoting health or well- being (not shown) are added, particularly nutritional ingredients, comprises agar because of its water releasing ability.
- Example 1 it is taught that lipid may be added to the formulations described therein in amounts up to 10% w/w of the water (i.e to 2.5g in 25ml of water.)
- Example 2 therein teaches a formulation with 0.5g of omega 3 in 24g of water (approx.2%) and in Examples 4 to 5 the omega 3 level is 1g in 24g of water (approx.4%).
- Applicant found that with a bitter testing ingredient, such as bergamot, the oil and emulsifier, also present, did not adequately taste mask the product at such concentrations. They therefore undertook a series of experiments to see how they might better address the taste masking of ingredients in water releasing gels.
- Example 2a Starting formulation (no emulsion) Sample 1C - pH adjusted 1 [00131] In taste tests this product was very bitter. [00132] Applicant therefore decided to incorporate the ingredient with an offensive taste profile (exemplified with bergamot) into an emulsion as per Example 2b.
- Example 2b Sample 4C - Emulsion with low oil Ingredient Required mass 17 [ ] s po uc, c e o ae emulsion had a concentration of 0.3% w/w with water (0.08/25 x 100) did not improve the taste profile.
- Example 2c through 2f they increased the oil level in stages through 1.5%, 4.5%, 7.5% to a maximum of 10.5%.
- Example 2c (Sample 4d) Sample - Emulsion with increasing oil I di t R i d U it
- Example 2d Sample - Emulsion with increasing oil
- Example 2e Sample - Emulsion with increasing oil
- Example 2f Sample 4f - Emulsion with increasing oil I di t R i d U it [00135]
- Example 2g they explored incorporating Bergamot into variants of a ketogenic product they were developing (very high lipid content).
- Example 2g (5c) Sample 5C - 1/2 Keto Emulsion Sunflower oil 3 g Agar 0.24 g n had a concentration of 14% (3/21.5 x 100) did significantly improve the taste profile. The bitterness was reduced, but was still noticeable. Significantly, the immediate bitter taste disappeared very quickly. Thus, the higher concentration of lipid muted the bitterness. [00138] Based on the above finding Applicant pushed the oil content even higher to determine the impact on both taste and stability and the results are illustrated in Examples 2h to 2j.
- Example 2h (16% oil/water emulsion) Ingredient Required Mass Unit Ber amet 47% BPF 100
- a further improvement in taste was noted and the olive oil was considered a more palatable oil with better organoleptic properties than the sunflower oil.
- Example 2i (7b) (20% oil/water emulsion) Ingredient Required Mass Unit
- Example 2j (7c) (24% oil/water emulsion) Ingredient Required Mass Bergamet 47% BPF 1.00 g Bot Exampes and j were abe to success u y taste mask the bitterness of bergamot. They were also stable, by which is meant their was no phase separation of the oil and water components of the emulsion, and that the ingredient(s) did not precipitate out.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
The invention relates to a dosage form comprising one or more health ingredients. It takes the form of a stable, shearable, gel capable and includes at least one ingredient that requires taste masking. Taste masking is achieved by through the use of an oil/ water emulsion comprising over 14% by weight of the lipid based carrier as compared to the water content of the dosage form. The gel releases its' load when sheared, the oil elulsion droplets providing a temporary coating on the tongue blunting the taste of the ingredient requiring masking.
Description
A CONSUMABLE GEL FOR HEALTH [0001] This invention relates to a dosage form comprising one or more health ingredients, particularly, but not exclusively, dietary, nutritional or pharmaceutical ingredients. [0002] The dosage form is a stable, shearable, gel capable of delivering, particularly, multiple health ingredients in a single dosage form including at least one ingredient that requires taste masking, such as exemplified by bergamot, a bitter tasting ingredient. The dosage form may be used in human or animal health. [0003] The dosage form is, particularly, but not exclusively, capable of delivering high doses of dietary, nutritional or pharmaceutical ingredients including: water soluble, water insoluble and/ or lipid soluble ingredients, in a single delivery vehicle which would not readily lend themselves to delivery via tablets or capsules. By “high” is meant at least 1g of one or more health ingredients, although the at least one ingredient that requires taste masking may be present in amounts of from 0.1g, through 0.25g and 0.5g to 1g or more. [0004] Taste masking is achieved through the use of a high concentration oil/ water emulsion which is stabilised in a shearable gel and which releases its’ load when sheared, the oil elulsion droplets providing a temporary coating on the tongue blunting the taste of the ingredient requiring masking. [0005] By “high concentration” oil/ water emulsion is meant at least or over 14% by weight of the lipid based carrier as compared to the water content of the dosage form. BACKGROUND [0006] One of the most important factors in successfully developing health ingredients, particularly dietary, nutritional or pharmaceutical ingredients is ensuring patient compliance. [0007] Currently, multiple product formats are used to deliver each of multiple e.g. nutritional or other health, e.g. active pharmaceutical ingredients (API’s), products. The varied nature and number of such products leads to significant variability in compliance. [0008] These health products, dietary, nutritional or pharmaceutical products, may be preventative or curative in nature. They include: prescription products, over-the-counter (OTC) products, and nutraceuticals and dietary supplements including, for example, products containing: vitamins, minerals, elements, proteins, carbohydrates, lipids, extracts of plant origin e.g. traditional Chinese medicines (TCM) or other indigenous medicines etc, either alone or in combination.
[0009] Poor compliance may be a of a need to take e.g. multiple tablets, capsules or other dosage forms e.g. a tablet containing multiple vitamins, a capsule containing omega 3, a drink containing soluble fibre etc. [0010] Tablets and capsules may prove difficult to take (swallow), particularly for certain patient groups, such as children and the elderly. For large dose products, or difficult to formulate products, or combination products, large tablet size and multiple tablet doses create compliance issues. [0011] Other problems which effect patient compliance include the taste, smell or organoleptic feel of a product. The organoleptic properties may relate to aspects of product taste, product consistency, product texture, product mouth feel, longevity of taste and any other organoleptic sensation. Ingredients with unpleasant tastes are particular challenging and the focus of the claimed invention addresses products including such ingredient(s). [0012] Some products require a separate drink to facilitate swallowing or to wash residues from the mouth, or a separate solid composition to be co-administered. [0013] Examples include: replacement sugar products for hypoglycaemia, and whey protein, which is poorly dispersed in liquids, and is additionally required in large volumes. [0014] Also, a delivery device may be required, such as a spoon, a syringe, or some other metering device to aid consumption and dose delivery. The requirement of such an additional device may adversely impact on compliance. [0015] Other factors influencing effectiveness include the packaging, the chemical or physical stability of the composition, the bioavailability of the components, the visual appeal, and convenience of delivery. [0016] Alternative dosage forms to capsules and tablets include drinks or gels comprising liquids or semi-solids. [0017] “Energy gels” are typically highly viscous pastes containing thickeners, such as, xanthan gum. However, because they do not set, these products leave tongue residues that linger, may be unpleasant, and can irritate the oropharyngeal area, which may lead to coughing or choking. [0018] These highly viscous pastes or gel products are those that will flow but tend to flow slowly, with a high internal resistance and a consistency like honey or ketchup. These known highly viscous pastes may be Newtonian or non-Newtonian fluids and may be shear thinning or shear thickening in nature. However, they all share the property that despite a degree of resistance, they plastically deform under stress – even where such behaviour is also known to have a threshold, such as Bingham plastic behaviour. Typically,
these viscous pastes have a viscosity between about 5000 and about 50,000 cP. [0019] The term “set”, as used herein refers to jelly materials that set, and do not exhibit plastic behaviour upon stress, but rather behave elastically upon stress, to a failure point where the structure of the jelly breaks to irreversibly create new interfaces. [0020] Applicant addressed this general problem in WO2019/215641 by developing a base gel comprising two different gelling agents: x a primary gelling agent which was an agarose-based polymer gelling agent, such as, an agar, and x a polyvalent ion gelled polymer which was an alginate-based polymer gelling agent, such as, but not limited to calcium alginate. [0021] The details disclosed therein are incorporated by reference. The agarose-based polymer provides the key functional characteristics, namely it forms, in the amounts provided, a firm hydrated gel, with a bloom grade of between 100 and 250, which does not exhibit plastic behaviour upon stress, but rather behaves elastically upon stress, to a failure point where the structure of the gel breaks or shears irreversibly releasing water and creating new interfaces, making it more fluid when ingested, such that it is a drinkable gel. [0022] The specification teaches forming emulsions incorporating up to 10% by weight of an oil or lipophilic components based on the water content of the dosage form. [0023] This application addresses a specific challenge of taste masking in agarose-based polymer gels (which can be sheared to release water) and incorporate oils. Simultaneously, it needed to ensure the gels remained stable and functional. It has been designed to deliver one or more ingredients with an unpleasant taste, which ingredient(s) may be present in an amount, by weight, of from 0.1g upwards. BRIEF SUMMARY OF THE DISCLOSURE [0024] In accordance with a first aspect of the invention there is provided an oral dosage form comprising x an ingredient requiring taste masking, x a first gelling agent, which is an agarose-based polymer gelling agent present in concentrations of between 0.001g (1mg) and 0.03g (30mg) per gram of water which concentration ensures hydration of, and the formation
of, a firm gel with a bloom of between 100 and 250, and which does not exhibit plastic behaviour upon stress, but rather behaves elastically upon stress, to a failure point where the structure of the gel breaks or shears to irreversibly create new interfaces, making it more fluid when ingested, such that it is a drinkable gel; and x an oil/ water emulsion comprising: o at least one lipid-based carrier; o water; and o an emulsifier, wherein the oil/water emulsion comprises at least 14% by weight of the lipid based carrier, based on the water content. [0025] More typically the first gelling agent, which is an agarose-based polymer gelling agent is present in concentrations of between 0.001g (1mg) and 0.02g (20mg) per gram of water [0026] The premise of the invention is based around ensuring droplets of emulsified oil are released from the gel when it shears such that they temporarily coat the tongue, blunting the taste of any ingredient(s) incorporated in the gel which are unpleasant (to receptors on the tongue). [0027] Thus, the invention requires sufficient lipid-based carrier (oil) and emulsifier to achieve its’ function as an effective taste masker whilst retaining the stability of the gel. [0028] By stable is meant there is no phase separation of the oil and water components of the emulsion, and that the ingredient(s) did not precipitate out. [0029] Selecting an oil that also provides desirable organoleptic properties was also required. [0030] Any suitable oil including vegetable oils, seed oils, and marine oils can be used together with blends thereof. [0031] Preferred oils were olive oil, sunflower oil, canola oil, coconut oil and oils containing medium chain triglycerides. Olive oil was particularly favoured for its neutral and organoleptic properties. [0032] In contrast to the invention disclosed in WO2019/215641 the invention can be used with a single agarose based gelling agent, and it is the greater concentration of the emulsified oil that provides the effective taste masking – since it is the release of the emulsified oil on shearing that provides a “protective” (taste blunting) coating to the tongue.
[0033] Agar proved particularly beneficial in providing enhanced stability. [0034] Applicant has determined that the optimum concentration of emulsified oil (by weight) is between 14% and 28% by weight of oil to water, although Applicant has determined that it is possible, in some circumstances, to get as much as 30% by wt of oil to water. [0035] More preferably, the emulsified oil comprises at least 20% by weight the lipid based carrier. [0036] The incorporation of an emulsifier further improves performance. A preferred emulsifier is one of lecithin, polyethylene glycol (PEG) and Polysorbate 80. [0037] The emulsifier should be present in an amount of from 0.1% to as much as 6.0% by weight. A preferred range is from 3% to 5%. Many other benefits of these shearable gels are as disclosed in WO2019/215641. [0038] A firm gel is a “set” gel or jelly characterised in an industrial and scientific context by the Bloom test, which is used to provide a relative firmness and strength of these gels. This test originated in 1925 by Oscar T. Bloom. The test determines the weight in grams needed by a specified plunger (normally with a diameter of 0.5 inch (11mm) to depress the surface of the gel by 4 mm, without irreversibly breaking the gel to create new interfaces, at a specified temperature. This result is the Bloom grade. A higher number indicates a stiffer product. For example, gelatin used in food usually runs from 125 Bloom to 250 Bloom. [0039] For the purpose of this document the terms gel and jelly are interchangeable. [0040] A set gel or jelly is somewhat elastic which means that under stress they deform, but when that stress is released they substantially return back to their original form. For example, if gently pressed by the underside of a spoon, a set jelly will be pushed down, but when the spoon is removed the original surface returns to its original position. It is not plastic, whereby under the same stress the surface would be deformed and then remain deformed once the pressure is removed. Set gels or jellys, rather than deform plastically, will fail by breaking irreversibly to create a new interface if the stress is further increased beyond its failure point. [0041] The oral dosage form of the invention may typically be provided in a volume of between 5ml and 250ml, depending on use, and is delivered from a container. For small containers (5-25ml) this may take the form of a sachet or straw, but for larger containers (25 to 250ml), this typically takes the form of a pouch, with a spout or straw, such that a sucking action shears the gel, such that it becomes more fluid with new interfaces being created, sometimes with the release of some water and the emulsion.
[0042] It is the shearing and creation of interfaces, and the concominent release of the emulsion which has the advantage that it facilitates powerful taste masking. [0043] The agarose-based polymer gelling agent, is preferaly, an agar. [0044] The agarose-based polymer gelling agent also advantageously behaves as an emulsifier so that additional emulsifiers are required in lesser amounts. [0045] A polyvalent ion gelled polymer, when used, is most preferably an alginate-based polymer gelling agent, such as, but not limited to calcium alginate. Alternatives include, guar gum, gellan gum, xanthan gum, pectin and kudzu. [0046] A particularly favoured combination of gelling agents comprise agar as the primary gelling agent and calcium alginate as the secondary gelling agent. This combination proved particularly versatile allowing combinations of two or more of water soluble, water insoluble and/ or lipid-based ingredients to be formulated together in a single dosage form. [0047] These two fundamentally different gelling agents provide a set gel structure via different interaction mechanisms. The advantage of the combination is its versatility as a base, as the combination overcome scenarios where gelation would otherwise by inhibited by the presence of different ingredients. [0048] Agar consists of a mixture of two polysaccharides: agarose and agaropectin, with agarose making up about 70% of the mixture. Agarose is a linear polymer, made up of repeating units of agarobiose, a disaccharide made up of D-galactose and 3,6-anhydro-L- galactopyranose. Agaropectin is a heterogeneous mixture of smaller molecules that occur in lesser amounts and is made up of alternating units of D-galactose and L-galactose heavily modified with acidic side-groups, such as sulphate and pyruvate. Any known variant of Agar may be used in the invention. [0049] Agar exhibits hysteresis, melting at 85°C and solidifying at from 32°C to 40°C. This property lends a suitable balance between easy melting and good gel stability, at relatively high temperatures. [0050] The gelling also helps provide stability, at room temperature (and above), meaning cold storage can be avoided. [0051] The most common alginate used in food is sodium alginate. In order to form a gel, sodium alginate needs to come into contact with divalent ions, such as calcium (Ca2+). When sodium alginate is added to a solution of a calcium salt, such as the chloride or citrate, a gel forms as the sodium ions (Na+) are exchanged with calcium ions (Ca2+) and the polymers become crosslinked. The divalent ions, such as calcium, are able to form crosslinks between alginate polymers because they can form two bonds, whereas
monovalent ions, such as sodium, can form one bond. The longer the alginate is in contact with the divalent ion solution, the more rigid the gel will become, as more crosslinks are formed. Also, depending on the concentration of divalent ions, the gels are either thermo-reversible (at low concentrations) or thermos-irreversible (at high concentrations). [0052] Alginic acid is a linear copolymer with homo-polymeric blocks of (1-4)-OLQNHG^ȕ-D- mannuronate (M), and its C-5 epimer, Į-L-guluronate (G), which are covalently linked together in different sequences or blocks. [0053] Sodium alginate is the sodium salt of alginic acid. Its empirical formula is NaC6H7O6. Sodium alginate is a gum, extracted from the cell walls of brown algae. [0054] Potassium alginate is a chemical compound that is the potassium salt of alginic acid. Its empirical chemical formula is KC6H7O6. [0055] Calcium alginate, made from sodium alginate from which the sodium ion has been removed and replaced with calcium, has the chemical formula C12H14CaO12. [0056] The gel formulation of the invention can be used to deliver unpleasant tasting ingredients, including those which are: i) Water soluble; ii) Water insoluble; or iii) Lipids [0057] .Typically, but not essentially, a dose including upwards of 0.1g of at least one ingredient requiring taste masking and optionally, between 1g and 40g of additional ingredients is delivered in a volume of between 5 and 45 ml of gel. These ingredients can include other nutraceutical or health ingredients. [0058] The base gel formulation can be used to load a single ingredient requiring taste masking, but the format makes it particularly effective for delivering multiple health ingredients, including the ingredient requiring taste masking, in a simple to take, simple to use dosage form which can retain ingredients which would typically be difficult to formulate in a single dosage form due to their different properties and can be administered orally by squeezing or sucking the gel from its container. [0059] A single ingredient requiring taste masking, is most likely to be delivered in a smaller volume format (5ml to 25ml), whereas a larger format (25ml to 250ml) is preferred where multiple health ingredients, particularly those required in large doses, and are required alongside the ingredient(s) requiring taste masking.
[0060] Such multiple health ingredients include, for example, proteins, carbohydrates, dietary fats, vitamins and minerals. [0061] The Proteins optionally include: milk protein concentrate, whey protein concentrate, soya protein isolate, and sodium caseinate which may additionally include Amino Acids such as one or more of: L-Glutamine, L-Glycine, L-Leucine, L-Isoleucine, L-Valine, Beta Alanine, L-Arginine, and Taurine. [0062] The Carbohydrates optionally include, for example: maltodextrin, inulin, fructose, and glucose syrup. [0063] The Dietary Fats optionally include: vegetable fats and oils, fish oils, coconut oil, mono, di and triglycerides of fatty acids, and lecithin. [0064] The Vitamins optionally include: Vitamin C (Ascorbic Acid), Vitamin K (Menaquinone-7), Vitamin E (dl-Alpha Tocopheryl Acetate), Niacin (Niacinamide), Vitamin A (Retinyl Acetate), Pantothenic Acid (Calcium D-Pantothenate), D-Biotin, Folic Acid, Vitamin D (Cholecalciferol), Vitamin B6 (Pyridoxine Hydrochloride), Riboflavin (Riboflavin 5 Phosphate Sodium), Thiamin (Thiamin Hydrochloride), Vitamin B12 (Cyanocobalamin), Creatine Monohydrate, beta carotene, lutein, lycopene oleoresin, choline chloride, L- carnitine, nicotinamide, calcium D-pantothenate, riboflavin, pyridoxine hydrochloride, pteroylmonoglutamic acid, phytomenadione, resveratrol, Alpha Ketoglutarate, Calcium Hydroxy Methylbutyrate (HMB), Tricreatine Malate. [0065] The Minerals optionally include Essential and Trace Mineral sources and salts such as one or more of: Tri-potassium Citrate, Sodium Chloride, Trisodium Citrate, Magnesium Oxide, Zinc Gluconate, Iron Fumarate, Manganese Gluconate, Copper Gluconate, Potassium Iodide, Sodium Molybdate, Chromium Picolinate, sodium selenite, chromium chloride, potassium iodide, sodium fluoride, sodium chloride, potassium chloride, calcium hydroxide, sodium ascorbate, magnesium hydroxide potassium hydroxide, ferrous lactate, zinc sulphate, manganese sulphate, and Phosphates such as one or more of sodium triphosphate, tricalcium phosphate, potassium phosphate. [0066] Some or all of these may be incorporated into the emulsion. [0067] Other components may include: [0068] Antioxidants, such as one or more of: ascorbyl palmitate, vitamin C (ascorbic acid) and vitamin E (d-alpha tocopherol). [0069] A pH modifier, such as one or more of: citric acid, and ascorbic acid, being used in amounts to provide a pH of from 4 to 7. [0070] Preservatives, such as sorbic acid. or a salt thereof e.g. potassium sorbate
[0071] In one embodiment the gel of the is used to deliver ingredients in the form of an entrapped stable emulsion. [0072] The lipid component, for example, sunflower or olive oil, is emulsified with the water, usually with stirring, and then caused to gel with the agar. Additional emulsifying agents may be added to facilitate the emulsification prior to gelling. [0073] Typical food grade or pharmaceutical grade emulsifiers, such as, for example a lecithin, esters of monoglycerides of fatty acids and mono, di and tri glycerides of fatty acids are added. [0074] The provision of multi-phase combinations can be accomodated. For example, an ingredient may be more stable in an oil in water emulsion. The set gel formed can trap & immobilise multiple phases enhancing stability as well as e.g. masking taste. The set gel is easily sheared during delivery to form new wet interfaces thereby facilitating delivery and taste masking through the release of the emulsion. [0075] In its stored state the formulation has a firm jelly form, is stable at room temperature, but when sucked or otherwise subjected to a gentle force, shears to create new wet interfaces which facilitate swallowing. Swallowing is eased because the gel interfaces created are slippery because they are inherently wet, due to the water within the structure. [0076] This novel formulation provides a chemically and physically stable matrix which can be used to entrap water soluble components, non-water soluble lipids, and lipid soluble components alike and provide effective taste masking. [0077] As a result of the entrapment, there is a reduced surface contact to taste buds but when sheared the emulsion is released coating the tongue thereby blunting taste. Unlike viscous paste gels, the gels of the present invention provide minimal residues, other than displaced water, and are very much easier to swallow as a set jelly will shear on sucking in contrast to alternative solid/semi-solid formats that are plastic (not elastic). [0078] Advantageously, because they shear, they release components quickly, even in high doses, and the released emulsion provides additional taste masking. [0079] Unlike tablets or capsules the platform is highly flexible in allowing different health ingredients to be provided in combinations in a single dosage form which has benefits over the alternatives currently on offer. [0080] The additional use of an alginate means that some beneficial calcium salts can be incorporated as part of the gelling process. Thus, for formulations directed towards bone
health Calcium and / or Magnesium salts calcium citrate or carbonate) will aid gelation by complexing. Calcium citrate may also enhance flavour. [0081] Solid suspensions may include nano-milled materials, such as, curcumin or glucosamine in a format which may enhance their bioavailability. [0082] Agar provides clear gels, without coloured specks. However, Agar and alginate gels are also visually very clear, but more importantly the alginate cross links provide a more structured gel with a different gelling mechanism to the carbohydrate non-ionic gelled polymers improving versatility and performance. [0083] However, adding Ca, Mg and Zn salts, such as chloride or citrate, interferes with the setting of Agar and some other gum polymers. Thus, to obtain good setting results Agar and Alginate should be used in particular ratios (w/w). The preferred ratios favour an excess of agar to alginate, and thus a ratio of between 8:1 to greater than 1:1, more preferably 5:1 to greater than 1:1 and most preferably about 3: greater than 1 Agar to Alginate is preferred. The Agar acts as an emulsifier and gelling agent, whilst the alginate together with the metal 2+ ions (Ca2+, Mg2+, Zn2+) form a structured gel counteracting the effect of these ions where only Agar is present. [0084] Agars and alginates are both suitable for vegans, vegetarians and most religious diets whereas gelatine is not, as it’s an animal protein, usually obtained from pigs. [0085] The advantage of combining agar and alginate gels is that they are less sensitive to temperature effects than other gelling agents. They are also less affected by components that may inhibit gelation, such as oils, changes in pH, and high concentrations of complex carbohydrates, such as, maltodextrins. Agar and alginate gels also tend to be faster setting, which is an advantage in manufacturing, facilitating faster and more robust production. [0086] The lipids used in the practising of the invention included any suitable food grade oil of animal or plant origin. Non-limiting examples include: corn oil, olive oil, sunflower oil, and coconut oil.The lipid material may advantageously include lipid vitamins such as any of vitamin D or vitamin E. [0087] Other preferred features include [0088] A dosage form including one or more health ingredients which are water soluble ingredients and lipid soluble ingredients. [0089] A dosage form wherein the one or more water soluble health ingredients are selected from the group comprising or consisting of water soluble vitamins, carbohydrates, sugars and amino acids.
[0090] A dosage form wherein the one or more lipid-soluble ingredients are selected from the group comprising or consisting of: oils, particularly fish and algal oils, DHA, EPA and lipid soluble vitamins D and E. [0091] A dosage form comprising one or more of a protein, vitamin, mineral, trace elements and a plant or marine extracts. [0092] A dosage form wherein the one or more health ingredients are present in an amount of at least 1g. [0093] A dosage form further comprising a second gelling agent which is a polyvalent ion gelled polymer gelling agent which is an alginate-based polymer gelling agent. [0094] Preferably the first gelling agent is present in an amount greater than the second gelling agent and more preferably still the agarose-based polymer gelling agent and alginate-based polymer gelling agent are present in a ratio of from greater than 1:1 to 3:1. [0095] Furthermore the dosage form is packaged in either: a pouch with an opening for facilitating the drinking of the gel by squeezing and/ or sucking; a sachet or straw; a syringe; or any other packaging facilitating delivery by sucking, squeezing or pushing the gel from the packaging. [0096] In addition – compliance of animal species such as pets, farm animals, or other domesticated animals for veterinary products is a challenge, as it can be very challenging for animal carers to ensure animals consume oral delivery forms such as tablets or capsules or powders. [0097] The benefits can also be provided to improve veterinary product compliance. [0098] Benefits of the invention include: x Taste masking: The gels of the invention allows any mixture of nutrients and most poor, strong & unpleasant flavours – such as bitterness, sweetness, fish oils, curcumin (spice/peppery) to be masked. x Large volumes of nutrients may additionally be formulated in one easy to consume dosage form: Multiple ingredients and large doses can be combined in a single dosage form.
x Overcomes choking risks posed by tablets: Gels are much easier to swallow than pills. The format aids all swallowing issues, whether young children or the elderly or merely those who have a predisposed swallowing problem. x Stable at room temperature. The gel nature provides stability without the need for cold storage. x Includes water as an ingredient. The presence of “locked up” but “releasable” water also ensure hydration is achieved, even if released as an emulsion, and no additional fluids are required to enable the product to be swallowed. This also helps aid digestion and provides an improved mouth feel. BRIEF DESCRIPTION OF THE DRAWINGS [0099] Embodiments of the invention are further described hereinafter with reference to the accompanying drawing, in which: Fig 1 is an illustration of a dispensing dosage form of the invention. DETAILED DESCRIPTION [00100] The general process for the preparation of a gel formulation is set out in Example 1 below: Example 1 Production methodology [00101] Any water-soluble ingredients are dissolved in water first. These may include a nutritional ingredient such as glucose, as well as preservatives and dilute acids (for pH control). An exemplary preservative is potassium sorbate, and an exemplary pH control agent, if required, is a weak acid, such as, citric acid, ascorbic acid, acetic acid or dilute HCl. [00102] To facilitate efficient addition of the gelling agent(s), the solution is preferably stirred and heated to near boiling. The agar and optionally sodium alginate are added slowly, to allow for gradual hydration, with steady constant stirring, ensuring satisfactory dispersion or dissolution. The dispersion or solution is kept at or around boiling point for a time, between 4-5 minutes, sufficient to ensure proper hydration, especially of the agar.
[00103] A separate emulsion is formed oil , water and any other ingredient to be incorporated into the emulsion. [00104] The two components are then mixed and the finished product is filled into e.g. sachets and allowed to cool such that it forms a firm gel. [00105] The sachet may be a simple sachet or tube for small volumes (5-25ml) or for larger volumes (25 to 250ml) a pouch, as illustrated in Fig 1. The pouch (1) is formed from, for example, plastics or foil layers that are sealed together around an edge (3) incorporating a filling and dispensing aperture comprising a plug (4), spout (5) and cap (6). The pouch is filled through the mouth piece (5) and is secured with a cap (6) which may be provided with a frangible seal. In use the subject removes the cap and drinks the gel by squeezing it and/ or sucking it from the pouch (1) through the spout (5). [00106] Alternative packaging for delivery may include a sachet or straw; a syringe; or any other packaging facilitating delivery by sucking, squeezing or pushing the gel from the packaging. [00107] When preparing the gel it is desirable to limit the heating period to minimise water loss from evaporation as excessive evaporation can lead to product variability. [00108] Preferably the agar is used in concentrations of between 0.001g (1mg) and 0.02g (20mg) per gram of water. More preferably between 0.005g (5mg) and 0.01mg (10mg) per gram of water, and most preferably between 0.006g (6mg) and 0.009g (9mg) mg per gram (equivalent to 1ml) of water. [00109] If used, the alginate is used in concentrations of between 0.0005g (0.05mg) and 0.01g (10mg) per gram of water. More preferably between 0.001g (1mg) and (0.008g (8mg) per gram of water, and most preferably between 0.001g (1mg) and 0.005g (5mg) per gram of water. [00110] With the alginate a source of divalent ions is added to enhance the alginate gel formation. Suitable ingredients include calcium, zinc and/ or magnesium salts. For example, calcium citrate, magnesium citrate or zinc citrate are good forms of soluble salts and can also provide mineral supplementation. Other salts may however be used. [00111] Favoured lipids for forming the emulsion are neutral oils such as olive oil and sunflower oil. Typically, the lipid level is added in concentrations of from 14 to 28%, but in certain circumstances up to 30%, w/w of the total water. The water component may be “split” and the gel and emulsion mixed. [00112] A mechanical homogeniser, such as a Silverson homogeniser, is advantageously used to facilitate the formation of an emulsion. Any known food grade emulsifier may be
added to improve the emulsion quality and stability, such as, for example, a lecithin. Preferably the emulsifier is non-animal sourced, such as soya lecithin, rather than egg lecithin. [00113] In an advantageous process the emulsion is, as noted above, made as a separate cool water mix precursor, and is combined with a separate hot agar in water precursor, (the water being split as appropriate) to speed cooling and gel formation. [00114] Further components may be dissolved or dispersed into the gel or emulsion. Where a nutritional component is neither water or lipid soluble, this may be prepared as a suspension in either lipid or water. It is advantageous if this component is milled to a fine particle size, as this may improve suspension stability, and may also improve bioavailability. Advantageously the insoluble component may be milled in wet or dry conditions, and may be ball milled, or media milled or nano-milled or milled in a high shear homogeniser. The milling may be conducted in the presence of a milling aid, such as leucine, sodium lauryl sulphate, and metal stearates. [00115] After heating, this liquid formulation can be metered hot into the desired containers and allowed to set as a gel. [00116] More specifically for e.g. a product for hypoglycaemia, during the manufacturing processing the following are undertaken: [00117] The gel production process involves the following: [00118] Weigh the non-gelling agents (e.g. glucose, potassium sorbate, water) in appropriate scaled quantities and add them to a suitable mixing vessel, in the order of e.g. Glucose (or other carbohydrate) as required; potassium sorbate or other preservative as needed, and water. [00119] Apply steady stirring, e.g. at lab scale this is a magnetic stirrer bar. Cover to minimise evaporation and water loss. [00120] Pre-weigh the specified nutrients required for composition. Mix these non-gelling ingredients while applying heat to the vessel contents. Add one nutrient at a time to the vessel, and allow for it to be fully dispersed and dissolved, then add the next nutrient. When all the nutrients have been added, allow to mix for an additional 2-3 minutes. [00121] Pre-weigh the gelling agent (agar agar). [00122] Stir for 2-3 minutes to ensure all the agents that have been incorporated and are no longer visible. Where insoluble components are used, incorporate using a homogeniser.
[00123] Mechanically form an emulsion the lipids, some of the water and at least the ingredient(s) to be taste masked using a homogeniser, heating as appropriate. [00124] Add the emulsion to the gel fraction and allow the formulation to cool and gel. [00125] The Bloom test is used to characterise the resulting grade of the set gel. Preferably, a Bloom grade of at least 100 through 110, 120, 130 and 140 is obtained. [00126] Preferably, a Bloom grade of less than 250, less than 220, less than 200 to less than 180 is obtained. [00127] An optimal Bloom grade of between 140 and 180 is desired. Example 2 Development and testing [00128] A preferred base gel, into which a plurality of ingredients promoting health or well- being (not shown) are added, particularly nutritional ingredients, comprises agar because of its water releasing ability. [00129] In WO2019/215641, Example 1, it is taught that lipid may be added to the formulations described therein in amounts up to 10% w/w of the water (i.e to 2.5g in 25ml of water.) Example 2 therein teaches a formulation with 0.5g of omega 3 in 24g of water (approx.2%) and in Examples 4 to 5 the omega 3 level is 1g in 24g of water (approx.4%). [00130] Applicant found that with a bitter testing ingredient, such as bergamot, the oil and emulsifier, also present, did not adequately taste mask the product at such concentrations. They therefore undertook a series of experiments to see how they might better address the taste masking of ingredients in water releasing gels. Key test data is set out in the Examples below:Example 2a – Starting formulation (no emulsion) Sample 1C - pH adjusted 1
[00131] In taste tests this product was very bitter. [00132] Applicant therefore decided to incorporate the ingredient with an offensive taste profile (exemplified with bergamot) into an emulsion as per Example 2b. Example 2b (Sample 4C)
Sample 4C - Emulsion with low oil Ingredient Required mass 17
[ ] s po uc, c e o ae emulsion had a concentration of 0.3% w/w with water (0.08/25 x 100) did not improve the taste profile. [00134] In Examples 2c through 2f they increased the oil level in stages through 1.5%, 4.5%, 7.5% to a maximum of 10.5%. Example 2c (Sample 4d) Sample - Emulsion with increasing oil I di t R i d U it
Example 2d Sample - Emulsion with increasing oil
Example 2e Sample - Emulsion with increasing oil Ingredient Required mass Unit
Example 2f Sample 4f - Emulsion with increasing oil I di t R i d U it
[00135] There was a noticeable improvement in taste at the highest concentrations, but the product was still considered unpalatable. [00136] In Example 2g they explored incorporating Bergamot into variants of a ketogenic product they were developing (very high lipid content). Example 2g (5c) Sample 5C - 1/2 Keto Emulsion
Sunflower oil 3 g Agar 0.24 g
n had a concentration of 14% (3/21.5 x 100) did significantly improve the taste profile. The bitterness was reduced, but was still noticeable. Significantly, the immediate bitter taste disappeared very quickly. Thus, the higher concentration of lipid muted the bitterness. [00138] Based on the above finding Applicant pushed the oil content even higher to determine the impact on both taste and stability and the results are illustrated in Examples 2h to 2j. Example 2h (16% oil/water emulsion) Ingredient Required Mass Unit Ber amet 47% BPF 100
[00139] A further improvement in taste was noted and the olive oil was considered a more palatable oil with better organoleptic properties than the sunflower oil. Example 2i (7b) (20% oil/water emulsion) Ingredient Required Mass Unit
Example 2j (7c) (24% oil/water emulsion)
Ingredient Required Mass Bergamet 47% BPF 1.00 g
Bot Exampes and j were abe to success u y taste mask the bitterness of bergamot. They were also stable, by which is meant their was no phase separation of the oil and water components of the emulsion, and that the ingredient(s) did not precipitate out. Conclusion [00140] From the tests conducted Applicant broadly concluded: x 0.3% to 10.5% of a lipid based carrier gave a stable gel with a soft texture but the emulsion did not adequately taste mask bitterness/bergamot; x 10.5% to 14% of lipid based carrier gave a stable gel with a firmer texture and the emulsion reduced bitterness. As the concentration increased there was a significant and noticable improvement compared to the prior art oils; x 14% to 28.0% (and up to 30% not shown) oil gave a stable gel with the firmest texture which very significantly removed the bitterness taste and additionally, where an unpleasant taste was perceived it was only short lived. [00141] It will be appreciated that the skilled nutritionist will be able to formulate multiple variations of the above using their general skill and knowledge.
Claims
CLAIMS 1. An oral dosage form comprising x an ingredient requiring taste masking; x a first gelling agent, which is an agarose-based polymer gelling agent present in concentrations of between 0.001g (1mg) and 0.03g (30mg) per gram of water which concentration ensures hydration of, and the formation of, a firm gel with a bloom grade of between 100 and 250, and which does not exhibit plastic behaviour upon stress, but rather behaves elastically upon stress, to a failure point where the structure of the gel breaks or shears to irreversibly create new interfaces, making it more fluid when ingested, such that it is a drinkable gel; and x an oil/ water emulsion comprising: o at least one lipid-based carrier; o water; and o an emulsifier, wherein the oil/water emulsion comprises at least 14% by weight of the lipid based carrier, based on the water content.
2. A dosage form as claimed in claim 1 wherein the oil/water emulsion comprises at least 20% by weight of the lipid based carrier, based on the water content.
3. A dosage form as claimed in any of the preceding claims wherein the oil/water emulsion comprises a maximum of 30% by weight of the lipid based carrier, based on the water content.
4. A dosage form as claimed in any of the preceding claims wherein the agarose- based polymer gelling agent is agar.
5. A dosage form as claimed in any of the preceding claims wherein the lipid based carrier is selected from olive oil, sunflower oil, coconut oil and a medium chain triglyceride (MCT) oil, or bends including such oils.
6. A dosage form as claimed in any of the preceding claims wherein the emulsifier is lecithin, polyethylene glycol (PEG) or Polysorbate 80.
7. A dosage form as claimed in any of the preceding claims further comprising one or more preservatives.
8. A dosage form as claimed in claim 7 the preservative is sorbic acid.
9. A dosage form as claimed in any of the preceding claims further comprising a pH modifier.
10. A dosage form as claimed in claim 9 wherein the pH modifier is used in an amount to maintain the pH in the range of 4 to 7.
11. A dosage form as claimed in any of the preceding claim further comprising one or more health ingredients in addition to the ingredient(s) requiring taste masking.
12. A dosage form as claimed in claim 11 wherein the further one or more health ingredients is selected from water soluble ingredients and lipid soluble ingredients.
13. A dosage form as claimed in claim 12 wherein the further one or more water- soluble health ingredients are selected from the group comprising or consisting of: water soluble vitamins, carbohydrates, sugars, and amino acids.
14. A dosage form as claimed in claim 12 wherein the one or more lipid-soluble ingredients are selected from the group comprising or consisting of: oils, particularly fish and algal oils, DHA, EPA and lipid soluble vitamins D and E.
15. A dosage form as claimed in claim 12 further comprising one or more of a protein, vitamin, mineral, trace elements and a plant or marine extracts.
16. A dosage form as claimed in any of claims 12 to 15 wherein the one or more health ingredients are present in an amount of at least 1g.
17. A dosage form as claimed in any of the preceding claims further comprising a second gelling agent which is a polyvalent ion gelled polymer gelling agent which is an alginate-based polymer gelling agent.
18. A dosage form as claimed in claim 17 wherein the first gelling agent is present in an amount greater than the second gelling agent.
19. A dosage form as claimed in claim 18 wherein the agarose-based polymer gelling agent and alginate-based polymer gelling agent are present in a ratio of from greater than 1:1 to 3:1.
20. A dosage form as claimed in any of the preceding claims which is packaged in either: a pouch (1) with an opening (5) for facilitating the drinking of the gel by squeezing and/ or sucking; a sachet or straw;
a syringe; or any other packaging facilitating delivery by sucking, squeezing or pushing the gel from the packaging.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2211290.8 | 2022-08-03 | ||
GBGB2211290.8A GB202211290D0 (en) | 2022-08-03 | 2022-08-03 | A consumable gel for health ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024028788A1 true WO2024028788A1 (en) | 2024-02-08 |
Family
ID=84540758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2023/057834 WO2024028788A1 (en) | 2022-08-03 | 2023-08-02 | A consumable gel for health ingredients |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB202211290D0 (en) |
WO (1) | WO2024028788A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1669090B1 (en) * | 2003-09-12 | 2016-03-30 | Ryukakusan Co. Ltd. | Bitterness-masking particulate jelly beverage |
WO2019215641A1 (en) | 2018-05-09 | 2019-11-14 | Domalina Pty Ltd ATF the Domalina Unit Trust | A consumable gel delivery method for health ingredients |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201916960D0 (en) * | 2019-11-21 | 2020-01-08 | Vitus Group As | Compositions |
GB202105461D0 (en) * | 2021-04-16 | 2021-06-02 | Vitux Group As | Compositions |
-
2022
- 2022-08-03 GB GBGB2211290.8A patent/GB202211290D0/en not_active Ceased
-
2023
- 2023-08-02 GB GB2311892.0A patent/GB2623158A/en active Pending
- 2023-08-02 WO PCT/IB2023/057834 patent/WO2024028788A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1669090B1 (en) * | 2003-09-12 | 2016-03-30 | Ryukakusan Co. Ltd. | Bitterness-masking particulate jelly beverage |
WO2019215641A1 (en) | 2018-05-09 | 2019-11-14 | Domalina Pty Ltd ATF the Domalina Unit Trust | A consumable gel delivery method for health ingredients |
US20210244061A1 (en) * | 2018-05-09 | 2021-08-12 | Domalina Pty Ltd ATF the Domalina Unit Trust | A consumable gel delivery method for health ingredients |
Non-Patent Citations (3)
Title |
---|
DILLE MORTEN J ET AL: "Bioactively filled gelatin gels; challenges and opportunities", FOOD HYDROCOLLOIDS, vol. 76, 23 December 2016 (2016-12-23), pages 17 - 29, XP085252135, ISSN: 0268-005X, DOI: 10.1016/J.FOODHYD.2016.12.028 * |
LU YAO ET AL: "Development of Emulsion Gels for the Delivery of Functional Food Ingredients: from Structure to Functionality", FOOD ENGINEERING REVIEWS, SPRINGER, US, vol. 11, no. 4, 4 July 2019 (2019-07-04), pages 245 - 258, XP036944594, ISSN: 1866-7910, [retrieved on 20190704], DOI: 10.1007/S12393-019-09194-Z * |
MALONE M E ET AL: "Gelled emulsion particles for the controlled release of lipophilic volatiles during eating", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 90, no. 2, 24 June 2003 (2003-06-24), pages 227 - 241, XP004431315, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(03)00179-2 * |
Also Published As
Publication number | Publication date |
---|---|
GB2623158A (en) | 2024-04-10 |
GB202211290D0 (en) | 2022-09-14 |
GB202311892D0 (en) | 2023-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3809877B1 (en) | A consumable gel delivery method for health ingredients | |
US10668013B2 (en) | Chewable gelled emulsions | |
JP5034946B2 (en) | Nutritional composition | |
WO2013146181A1 (en) | Emulsified food product composition | |
WO2006088418A1 (en) | A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base | |
KR20120104382A (en) | Liquid food composition | |
JP2019206518A (en) | Oil and fat-containing composition and oral preparation | |
WO2024028788A1 (en) | A consumable gel for health ingredients | |
JP2003530359A (en) | Oral delivery methods and formulations for solid drugs or dietary supplements | |
JP2016131501A (en) | Coated granular composition | |
WO2011128631A2 (en) | Vegetarian oral pharmaceutical and nutraceutical compositions | |
WO2023120685A1 (en) | Nutritional composition | |
JP6019577B2 (en) | Method for producing liquid emulsion composition | |
AU2017346941A1 (en) | Oral medication formulations | |
EA025571B1 (en) | Oral pharmaceutical dispersion compositions | |
TW201233341A (en) | Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23757345 Country of ref document: EP Kind code of ref document: A1 |